ProductNumber90/636ProductDescriptionHIV-1P24AntigenWHOInternationalStandardTypeofStandardWHOInternationalStandardCategoryDiagnostics>BloodbornepathogensInstructionsforUse90-636.pdfKeywordshumanimmunodeficiencyvirusserologyWHORelatedProducts00/562,03/262,05/122,08/150,09/110,09/186,09/188,11/216,12/226,13/214,90/636,95/522,02/210,CustomerNotesFreeze-dried.Storeat-20C.Shippedatambient.MinimumQuantity1流感抗原现货库存：09/274InfluenzaVirusInfectiousNYMCX-18598/762InfluenzaVirusinfectiousResvir-14(H3N2)90/784InfluenzaVirusinfectiousNIB-26(H3N2)05/102InfluenzaVirusinfectiousNYMCBX-712/202InfluenzavirusinfectiousNYMCBX-3900/530InfluenzaVirusinfectiousB/Sichuan/379/9905/138InfluenzaVirusinfectiousB/Shanghai/361/200212/202InfluenzavirusinfectiousNYMCBX-3913/116InfluenzaAntigenA/Texas/50/2012(NYMCX-223A)92/734InfluenzaVirusinfectiousA/Beijing/32/92(H3N2)92/738InfluenzaVirusinfectiousA/Shanghai/24/9093/568InfluenzaVirusinfectiousA/Beijing/359/89(H3N2)93/572InfluenzaVirusinfectiousA/Guizhou/54/89(H3N2)93/686InfluenzaVirusinfectiousA/Shangdong/9/93(H3N2)95/758InfluenzaVirusinfectiousA/Wuhan/359/95(H3N2)98/778InfluenzaVirusinfectiousA/Sichuan/346/98(H3N2)其他抗原抗体库存：97/648Anti-MeaslesserumRAIAnti-rabiesImmunoglobulin,Human83/575FollicleStimulatingHormone,Pituitary06/166AntithrombinConcentrate,Human90/636HIV-1P24Antigen08/258Antithrombin,Plasma(3rdInternationalStandard)13/242FEIBAConcentrate2ndNIBSCWorkingReferenceStandard92/680SerumamyloidAprotein.WHOInternationalStandard92/644Interleukin-1receptorantagonist(HumanrDNAderived)05/112LowMolecularWeightHeparinforMolecularWeightCalibration(2ndInternationalStandard)08/282Follicle-StimulatingHormone,human,recombinant,forbioassay(2ndInternationalStandard)10/2664thWHOInternationalStandardforHBVDNAforNAT14/150HepatitisCvirus(HCV)Fornucleicacidamplificationtechniques(5thInternationalstandard2015)13/146C-Peptide,Human.1stInternationalStandard93/556NerveGrowthFactor(Human,rDNAderived)16/194HIV-1RNA4thInternationalStandardAFP(72/225)Alpha-Foetoprotein83/500Insulin,Human09/2961stInternationalStandardforhumanProinsulin83/573(84/500)Prolactin,Human96/668Prostate-SpecificAntigenFree10/152CandidateHIV-1RNA3rdInternationalStandardPPDBOVPurifiedProteinDerivative(PPD)ofBovineTuberculinWHOInternationalStandardPPDAPurifiedProteinDerivative(PPD)ofMAviumTuberculinWHOInternationalStandard67/182Anti-RubellaSerum,Human12/226HBsAg(HBVgenotypeB4,HBsAgsubtypesayw1/adw2)(3rdInternationalStandard)93/526Batroxobin10/266(10/264)HepatitisBVirusforNucleicAcidAmplificationTechniques(3rdWHOInternationalStandard)07/164Anti-hepatitisBsurfaceantigen(Anti-HBs)immunoglobulin(2ndInternationalStandard)09/260Epstein-BarrVirus(1stInternationalStandard)B2MBeta-2Microglobulin75/595BloodCoagulationFactorXa,Bovine13/100ActivatedBloodCoagulationFactorXI(FXIa),Human(1stInternationalStandard)12/224HIV-1NATsubtypes(Main)(2ndInternationalReferencePreparationl)14/2904thHCVRNAGenotypePanelforNucleicAcidAmplification11/234(75/502)SerumImmunoglobulinE(IgE)Human88/646GranulocyteMacrophageColonyStimulatingFactor(Human,rDNAderived)WHOInternationalStandard87/640TumourNecrosisFactorbeta(Human,rDNAderived)WHOReferenceReagent85/506C-ReactiveProtein,Human92/510FollicleStimulatingHormone,Human,recombinant08/258Antithrombin,Plasma(3rdInternationalStandard)66/387Anti-thyroidMicrosomeSerum,Human06/202HPV16DNA06/206HPV18DNA94/572Ferritin,Human,recombinantRTF/16Thromboplastin,Human,Recombinant,Plain5thInternationalStandard201683/575FollicleStimulatingHormone,Pituitary73/601CarcinoembryonicAntigen(CEA),Human(1stInternationalReferencePreparation)RAIAnti-rabiesImmunoglobulin,Human80/505GrowthHormone,Human,PituitaryRUBI-1-94Anti-rubellaImmunoglobulin,Human75/551ChorionicGonadotrophinbetaSubunit,Human09/162HumanCytomegalovirus(HCMV)forNucleicAcidAmplificationTechniques(1stInternationalStandard81/535(80/552)LuteinizingHormone,Human,Pituitary91/530EpidermalGrowthFactor(Human,rDNAderived)09/264FibrinogenPlasma(D)(3rdInternationalStandard)NIBSC标准品BiotherapeuticsCytokinesandGrowthFactorsEndotoxinHaemostasisImmunogenicityImmunoglobulinsandimmuneseraProteinHormonesandEndocrineProductsQualityControlReagentUKStemCellBankMouseEmbryoFibroblastsDiagnosticsAllergenAnti-ToxinsBloodbornepathogensBloodTransfusionandTransplantationEbolaVirusGenomicReferenceMaterialHaematinicsandHaemoglobinHaemostasisHumanPapillomavirusImmunoglobulinsandimmuneseraMiscellaneousParasitologyParvovirusProteinHormonesandEndocrineProductsQualityControlReagentZoonosisandlivestockdiseasesVaccinesBotulinumClostridiumDiphtheriaEbolaVirusEntericdiseaseHaemophilusInfluenzaetypeb(Hib)HumanPapillomavirusInfluenzaJE/DengueMalariaMeningococcaltypingandELISAreagentsMMRParasitologyPertussisPneumococcalvaccinesPolioQualityControlReagentStaphylococcalImmuneSeraTetanusTuberculosisVacciniaYellowFeverZoonosisandlivestockdiseases00/410MAPRECassayofpoliovirustype1(Sabin).100%480-A,525-CDNA(1stInternationalReferencePreparation)InternationalReferencePreparation00/416LowMutantVirusReferenceforMAPRECassayofpoliovirustype1(Sabin)(1stInternationalReferencePreparation)InternationalReferencePreparation00/418MAPRECassayofpoliovirustype1(Sabin)(1stInternationalStandard)WHOInternationalStandard00/422HighMutantVirusReferenceforMAPRECassayofpoliovirustype1(Sabin)(1stInternationalReferencePreparation)InternationalReferencePreparation00/440InfluenzaAntiserumA/Singapore/1/57(H2)InfluenzaReagent00/442InfluenzaantiB/Yamanashi/166/98SerumInfluenzaReagent00/464Streptokinase(3rdInternationalStandard2001)WHOInternationalStandard00/500BotulinumTypeA-EAntitoxin,HumanSerumNonWHOReferenceMaterial00/530InfluenzaVirusinfectiousB/Sichuan/379/99InfluenzaReagent00/542Influenzaanti-A/Chick/Scotland/59(H5N1)SerumInfluenzaReagent00/544InfluenzaVirusinfectiousB/Victoria/504/00InfluenzaReagent00/546InfluenzaAntigenB/Johannesburg/5/99InfluenzaReagent00/552InfluenzaAntigenA/Duck/Singapore-Q/F119-3/97(H5N3)InfluenzaReagent00/556Influenzaanti-B/Johannesburg/5/99/SerumInfluenzaReagent00/562HepatitisAVirusforNucleicAcidAmplificationTechniques(2ndInternationalStandard)WHOInternationalStandard00/572InterferonBeta(Human,rDNA,Glycosylated)(3rdInternationalstandard)WHOInternationalStandard00/574InterferonBetaSER17Mutein(Human,rDNAderived)NonWHOReferenceMaterial00/576InterferonBeta(Human,Fibroblast-derived,Glycosylated)NonWHOReferenceMaterial00/614InfluenzavirusinfectiousB/Guangdong/120/2000InfluenzaReagent007SPHumanAnti-PneumococcalcapsuleReferenceSerum(1stInternationalStandard)WHOInternationalStandard01/412Anti-MeningococcalImmunotypeL3,7,9MonoclonalAntibodyNonWHOReferenceMaterial01/420Interleukin-17(HumanrDNAderived)(InternationalReferenceReagent)InternationalReferenceReagent01/424VascularEndothelialGrowthFactor,HumanrDNAderivedNonWHOReferenceMaterial01/426MeningococcalgroupYpolysaccharideNonWHOReferenceMaterial01/428MeningococcalserogroupWpolysaccharideNonWHOReferenceMaterial01/450InfluenzaantiB/Guangdong/120/2000SerumInfluenzaReagent01/452InfluenzaantiA/Panama/2007/99(H3N2)HAserumInfluenzaReagent01/506BotulinumtypeFantitoxin,equineNonWHOReferenceMaterial01/508BotulinumtypeCantitoxin,equineNonWHOReferenceMaterial01/510BotulinumAntitoxinEquineTypeDNonWHOReferenceMaterial01/512BotulinumtypeGantitoxin,equineNonWHOReferenceMaterial01/514Anti-MeningococcalSerosubtypeP1.7MonoclonalAntibodyNonWHOReferenceMaterial01/528OralPoliovaccineSabinType1referencestrain[LS-c,2abstrain](Panelof5ampoules)InternationalReferencePreparation01/532OralPoliovaccineSabinType3referencestrain(Panelof5ampoules)InternationalReferencePreparation01/538Anti-MeningococcalSerosubtypeP1.16mAbNonWHOReferenceMaterial01/546InfluenzaAntigenB/Guangdong/120/2000InfluenzaReagent01/572Anti-DImmunoglobulin(2ndInternationalStandard)WHOInternationalStandard01/580Thrombin,human(2ndInternationalStandard)WHOInternationalStandard01/600Anti-ToxoplasmaIgG,Human(InternationalStandard)WHOInternationalStandard01/602Anti-ParvovirusB19,plasma,human(2ndInternationalStandard)WHOInternationalStandard01/612InfluenzaVirusinfectiousB/Hawaii/10/01InfluenzaReagent01/614InfluenzaAntigenA/NewCaledonia/20/99InfluenzaReagent02/102InfluenzaantiA/Panama/2007/99SerumInfluenzaReagent02/144Anti-MeningococcalSerosubtypeP1.15mAbNonWHOReferenceMaterial02/148Anti-MeningococcalSerosubtypeP1.4mAbNonWHOReferenceMaterial02/168PrekallikreinActivator(PKA),Human(2ndInternationalStandard)WHOInternationalStandard02/178Anti-MeningococcalSerosubtypeP1.2mAbNonWHOReferenceMaterial02/180Anti-MeningococcalSerotypeP2.2amAbNonWHOReferenceMaterial02/182Anti-JapaneseEncephalitisVirusPlasma,HumanNonWHOReferenceMaterial02/184Anti-JapaneseEncephalitis(Anti-JE)VirusNegativeControlPlasma,HumanNonWHOReferenceMaterial02/206FactorXIIIPlasma,Human(1stInternationalStandard)WHOInternationalStandard02/210HIV(antibody),1stInternationalReferencePanelInternationalReferencePreparation02/226IVIGnegativecontrolforusewithIVIG+anti-D(InternationalReferenceReagent)InternationalReferenceReagent02/228IVIG+anti-DforusewithnegativecontrolIVIG(InternationalReferenceReagent)InternationalReferenceReagent02/230BiotinylatedBrad-5(Bio-Brad-5)WorkingStandard02/232TetanusToxoid(Non-Adsorbed)NonWHOReferenceMaterial02/254Insulin-likeGrowthFactor-1,recombinant,human,forimmunoassay(1stInternationalStandard)WHOInternationalStandard02/262InfluenzaVirusinfectiousB/Brisbane/32/2002InfluenzaReagent02/286VascularEndothelialGrowthFactor165(VEGF165)(recDNA,humansequence)(InternationalReferenceReagent)InternationalReferenceReagent02/294InfluenzaAntiserumA/chick/Italy/1347/99(H7N1)InfluenzaReagent02/308Anti-MeningococcalSerotypeP3.4mAbNonWHOReferenceMaterial02/310Anti-MeningococcalSerotypeP3.15mAbNonWHOReferenceMaterial02/318BotulinumAntitoxinEquineTypeENonWHOReferenceMaterial02/320Anti-MeningococcalSerosubtypeP1.3mAbNonWHOReferenceMaterial02/336InfluenzaAntigenA/NewCaledonia/20/99InfluenzaReagent02/338InfluenzaantiA/Panama/2007/99SerumInfluenzaReagent02/342ProteinCPlasma,Human(2ndInternationalStandard)WHOInternationalStandard03/104-018HTLV-1(antibody)MonitorSampleCEMarkedMaterial03/110InfluenzaantiB/Shangdong/9/97SerumInfluenzaReagent03/114Anti-MeningococcalSerosubtypeP1.1mAbNonWHOReferenceMaterial03/116BloodCoagulationFactorV,PlasmaHuman(1stInternationalStandard)WHOInternationalStandard03/124Thrombopoietin(HumanrDNAderived)NonWHOReferenceMaterial03/142Anti-MeningococcalSerosubtypeP1.14mAbNonWHOReferenceMaterial03/148Keratinocytegrowthfactor(KGF,FGF-7)(24-163)(1stInternationalReferenceReagent)InternationalReferenceReagent03/150KeratinocyteGrowthFactor(KGF,FGF-7)(1stInternationalReferenceReagent)InternationalReferenceReagent03/152Anti-HPA-1a(InternationalStandard)WHOInternationalStandard03/164Anti-Bminimumpotencyreferencepreparation(InternationalStandard)WHOInternationalStandard03/178VitaminB12,SerumFolateandholoTC(Internationalstandard)WHOInternationalStandard03/182Anti-MeningococcalSerotypeP3.21mAbNonWHOReferenceMaterial03/188Anti-Aminimumpotencyreferencepreparation(InternationalStandard)WHOInternationalStandard03/190Anti-HPA-3a(minimumpotency)(InternationalReferenceReagent)InternationalReferenceReagent03/192Thyroid-StimulatingHormone,Recombinant,Human,forBioassay(1stInternationalstandard)WHOInternationalStandard03/198InfluenzaVirusinfectiousA/Kumamoto/102/02InfluenzaReagent03/200Interleukin-18(HumanrDNAderived)(InternationalReferenceReagent)InternationalReferenceReagent03/210Anti-MeningiococcalSerosubtypeP1.6mAbNonWHOReferenceMaterial03/212InfluenzaantiA/Wyoming/03/03SerumInfluenzaReagent03/220InfluenzaAntigenA/Wyoming/03/03InfluenzaReagent03/224Anti-MeningococcalSerosubtypeP1.10mAbNonWHOReferenceMaterial03/226Anti-MeningococcalSerosubtypeP1.5mAbNonWHOReferenceMaterial03/228ProteinS,Plasma,Human(2ndInternationalStandard)WHOInternationalStandard03/236Anti-MeningococcalSerosubtypeP1.13mAbNonWHOReferenceMaterial03/242InfluenzaantiA/PuertoRico/8/34(H1N1)HASerumInfluenzaReagent03/244InfluenzaAntiserumA/chick/Germany/N/49InfluenzaReagent03/258InfluenzaAntigenA/NewCaledonia/20/99(IVR-116)InfluenzaReagent03/262HepatitisBSurfaceAntigensubtypeadw2,genotypeA(InternationalReferencePanel)InternationalReferencePreparation04/122Anti-MeningococcalSerosubtypeP1.12mAbNonWHOReferenceMaterial04/132IVIG+Anti-DforusewithnegativecontrolIVIGNonWHOReferenceMaterial04/140IVIGNegativeControlforusewithIVIG&Anti-DNonWHOReferenceMaterial04/150TetanusToxoidForFlocculationTest(2ndInternationalStandard)WHOInternationalStandard04/160InfluenzaVirusinfectiousNYMCX-147InfluenzaReagent04/166TNF-relatedApoptosis-InducingLigand(trail),Human,rDNA-derived(1stInternationalReferenceReagent)WHOInternationalStandard04/170InfluenzaVirusinfectiousA/Wellington/1/2004InfluenzaReagent04/172InfluenzaVirusinfectiousIVR-139InfluenzaReagent04/176PlasmodiumfalciparumDNAforNATAssays(1stInternationalStandard)WHOInternationalStandard04/198Anti-MeningococcalSerotypeP3.1mAbNonWHOReferenceMaterial04/200Parathyroidhormone1-34,Recombinant,Human(InternationalStandard)WHOInternationalStandard04/202InfluenzaAntigenB/Jiangsu/10/2003InfluenzaReagent04/214InfluenzaAntiserumA/VietNam/1194/04(H5N1)InfluenzaReagent04/224FactorVLeiden,HumangDNA,1stInternationalGeneticReferencePanel2004WHOInternationalStandard04/228InfluenzaantiB/NeuraminidaseSerumInfluenzaReagent04/242InfluenzaantiB/Jiangsu/10/2003HASerumInfluenzaReagent04/246Anti-MeningococcalSerogroupW-135mAbNonWHOReferenceMaterial04/248Anti-MeningococcalSerosubtypeP1.19mAbNonWHOReferenceMaterial04/252ProteinCConcentrate,Human(1stInternationalStandard)WHOInternationalStandard04/260InfluenzaantiA/NewCaledonia/20/99HASerumInfluenzaReagent04/262InfluenzaantiA/NewYork/55/2004HASerumInfluenzaReagent04/264InfluenzaAntigenA/NewYork/55/2004(H3N2)(NYMCX-157)InfluenzaReagent05/102InfluenzaVirusinfectiousNYMCBX-7InfluenzaReagent05/106Anti-HPA-1aminimumpotencyreagent(2ndInternationalReferencereagent)InternationalReferenceReagent05/110InfluenzaVirusinfectiousA/California/7/2004InfluenzaReagent05/112LowMolecularWeightHeparinforMolecularWeightCalibration(2ndInternationalStandard).WHOInternationalStandard05/122SyphiliticplasmaIgG(human)(1stInternationalStandard)WHOInternationalStandard05/130ProthrombinMutationG20210A,HumangDNA(1stInternationalGeneticReferencePanel2005)WHOInternationalStandard05/134Anti-humanpapillomavirustype16serum(1stInternationalStandard)WHOInternationalStandard05/138InfluenzaVirusinfectiousB/Shanghai/361/2002InfluenzaReagent05/162Alpha-1-Antitrypsin,plasmaderived(1stInternationalstandard)WHOInternationalStandard05/190AntiMeningococcalSerosubtypeP1.9MonoclonalAntibodyNonWHOReferenceMaterial05/192AntiMeningococcalSerotypeP2.2bMonoclonalAntibodyNonWHOReferenceMaterial05/234InfluenzaAntigenA/Hiroshima/52/2005(H3N2)(IVR-142)InfluenzaReagent05/236InfluenzaantiA/Wisconsin/67/2005SerumInfluenzaReagent05/242IVIG,Anti-DandNegativeControlPanelNonWHOReferenceMaterial05/252InfluenzaantiBNeuraminidaseSerumInfluenzaReagent06/108InfluenzaVirusinfectiousIVR-116InfluenzaReagent06/124MonoclonalAntibodyforSerotypingBordetellapertussisFimbrialAntigen2(1stInternationalStandard)WHOInternationalStandard06/128MonoclonalAntibodyforSerotypingBordetellapertussisFimbrialAntigen3(1stInternationalStandard)WHOInternationalStandard06/140PertussisAntiserum(human)1stIS-WHOinternationalStandard.WHOInternationalStandard06/142PertussisAntiserum(Human)1stWHOReferenceReagentInternationalReferenceReagent06/164InfluenzaVirusinfectious1VR-142InfluenzaReagent06/166AntithrombinConcentrate,Human(3rdInternationalStandard)WHOInternationalStandard06/170InfluenzaAntigenA/NewCaledonia/20/99InfluenzaReagent06/192InfluenzaantiA/turkey/Turkey/1/05(NIBRG-23)HAserum(sheepSH465&SH466)InfluenzaReagent06/202HumanPapillomavirus(HPV)Type16DNA(1stInternationalStandard)WHOInternationalStandard06/206HumanPapillomavirus(HPV)Type18DNA(1stInternationalStandard)WHOInternationalStandard06/242InfluenzaVirusInfectiousNYMCX-161B(A/Wisconsin/67/2005HGR)InfluenzaReagent07/102InfluenzaAntigenA/SolomonIslands/3/2006(H1N1)(IVR-145)InfluenzaReagent07/104InfluenzaantiA/SolomonIslands/3/2006(H1N1)(IVR-145)HASerumInfluenzaReagent07/112InfluenzaAntigenA/turkey/Turkey/1/2005(H5N1)NIBRG-23InfluenzaReagent07/132InfluenzaVirusinfectiousB/Malaysia/2506/2004InfluenzaReagent07/144InfluenzaVirusinfectiousIVR-145,InfluenzaReagent07/146InfluenzaantiA/HongKong/1073/99like(H9)HASerum(sheep)InfluenzaReagent07/148InfluenzaantiA/Vietnam/1194/04(H5N1)HASerumInfluenzaReagent07/150HumanPlasmaAnti-InfluenzaH5N1(1stInternationalStandard)WHOInternationalStandard07/164Anti-hepatitisBsurfaceantigen(Anti-HBs)immunoglobulin(2ndInternationalStandard)WHOInternationalStandard07/184InfluenzaantiB/Malaysia/2506/2004-HASerumInfluenzaReagent07/202Recombinantsolubletransferrinreceptor(rsTfR)(1stWHOReferenceReagent)InternationalReferenceReagent07/204InfluenzaVirusInfectiousNIBRG-60VE225820InfluenzaReagent07/214PositiveControlforuseinflowcytometrycrossmatching(FCXM)CEMarkedMaterial07/216DiphtheriaToxoid(Adsorbed)(4thInternationalStandard)WHOInternationalStandard07/222RhD/SRYPlasmaDNAsensitivitystandard(1stInternationalReferenceReagent)InternationalReferenceReagent07/226InfluenzaVirusInfectiousA/NewCaledonia/20/99InfluenzaReagent07/228BloodCoagulationFactorVIIa,Concentrate,Human,2ndInternationalStandard”WHOInternationalStandard07/246InfluenzaVirusInfectiousIVR-147InfluenzaReagent07/268InfluenzaVirusInfectiousB/Brisbane/3/2007InfluenzaReagent07/270BCGVaccineofDanish1331sub-strain(1stWHOReferenceReagent)InternationalReferenceReagent07/272BCGVaccineofTokyo172sub-strain(1stWHOReferenceReagent)InternationalReferenceReagent07/274BCGVaccineofRussianBCG-Isub-strain(1stWHOReferenceReagent)InternationalReferenceReagent07/278InfluenzaantiA/mallard/Netherlands/12/2000(H7)HAserum(NIBRG-60)(sheepSH474ANDSH475)InfluenzaReagent07/286-0140.05IUHBsAgMonitorSampleCEMarkedMaterial07/288-016HepatitisBSurfaceAntigenBritishWorkingStandard0.2IU/mlCEMarkedMaterial07/290InfluenzaAntigenA/Anhui/1/05(H5N1)IBCDC-RG-6InfluenzaReagent07/296-006InfluenzaVirus(A/Christchurch/1/2003,H1N1)forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN07/298-006InfluenzaVirus(A/Wyoming/3/2003,H3N2)forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN07/300-005InfluenzaVirus(B/Jiangsu/10/2003)forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN07/304Anti-DforassuringoperatorandtestperformanceWorkingStandard07/306Anti-Aandanti-BinIVIG:Positivecontrolforhaemagglutinationtests(InternationalReferenceReagent)InternationalReferenceReagent07/316BloodCoagulationFactorVIIIandVonWillebrandFactorinPlasma(6thI.S.)WHOInternationalStandard07/318MeningococcalGroupCPolysaccharideNonWHOReferenceMaterial07/328UnfractionatedHeparin(6thI.S.)WHOInternationalStandard07/336InfluenzaAntigenA/mallard/Netherlands/12/00(H7N3)NIBRG-60InfluenzaReagent07/338InfluenzaantiserumA/Anhui/1/05(H5)InfluenzaReagent07/348InfluenzaVirusinfectiousNYMCX-171BInfluenzaReagent07/350BloodCoagulationFactorVIIIConcentrate(8thI.S.)WHOInternationalStandard07/358InfluenzaVirusinfectiousNIB-50InfluenzaReagent07/362InfluenzaVirusinfectiousIVR-149InfluenzaReagent07/364ChorionicGonadotrophin,(5thInternationalStandard)WHOInternationalStandard07/B498-18QCRHBclgMQC1-IgMAnti-HBcQualityControlSerum:Sample1QualityControlReagent08/100InfluenzaAntigenA/Brisbane/59/2007(IVR-148)(H1N1)InfluenzaReagent08/108InfluenzaVirusInfectiousNIBRG-91InfluenzaReagent08/118-005ParainfluenzaVirusserotype3forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN08/120-006HumanRespiratorysyncytialvirusA2forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN08/126InfluenzaAntiN1NeuraminidaseSerumSH485InfluenzaReagent08/138InfluenzaVirusInfectiousB/Florida/4/2006InfluenzaReagent08/140InfluenzaAntigenB/Florida/4/2006InfluenzaReagent08/142InfluenzaantiserumA/Anhui/1/05(H5)InfluenzaReagent08/148PositivecontrolforLuminexbasedanti-HLAClassIIserologyCEMarkedMaterial08/150HIV-2RNA(1stInternationalStandard)WHOInternationalStandard08/154InfluenzaVirusInfectiousNIBRG-12InfluenzaReagent08/156InfluenzaVirusInfectiousNIBRG-2330060VE3InfluenzaReagent08/158FragileXSyndromegDNA(1stInternationalGeneticReferencePanel)WHOInternationalStandard08/160HaemophiliaA,Intron-22inversion,gDNA,(1stInternationalGeneticReferencePanel)WHOInternationalStandard08/174-007HumanCoxsackieB4forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN08/176-005ParainfluenzaVirusserotype1forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN08/178-005ParainfluenzaVirusserotype2forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN08/180-005Parainfluenzavirusserotype4forNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN08/184InfluenzaAntigenB/Malaysia/2506/2004InfluenzaReagent08/202InfluenzaantiA/chick/HongKong/G9/1997/(H9)HAserum(NIBRG-94)(H9N1)InfluenzaReagent08/204ThyroidStimulatingAntibody(2ndI.S.)WHOInternationalStandard08/208InfluenzaAntigenHongKong/1073/99(H9N2)InfluenzaReagent08/210InfluenzaantiA/Cambodia/R0405050/2007(H5)HAserum(NIBRG-86)InfluenzaReagent08/214MeningococcalSerogroupCpolysaccharide(1stInternationalStandard)WHOInternationalStandard08/216InfluenzaAntigenA/Cambodia/RO405050/2007(H5N1)InfluenzaReagent08/218TetanusToxoidAdsorbed(4thInternationalStandard)WHOInternationalStandard08/228InfluenzaAntigenA/chick/HongKong/G9/1997(H9N2)NIBRG-91InfluenzaReagent08/230Streptodornase(2ndInternationalStandard)WHOInternationalStandard08/246InfluenzaantiA/Brisbane/10/2007-likeHAserumInfluenzaReagent08/256C1-Inhibitor,Concentrate(1stInternationalStandard)WHOInternationalStandard08/258Antithrombin,Plasma(3rdInternationalStandard)WHOInternationalStandard08/262C1Inhibitor(Plasma)(1stInternationalStandard)WHOInternationalStandard08/266SexHormoneBindingGlobulin.(2ndInternationalStandard)WHOInternationalStandard08/268InfluenzaAntigenA/mallard/England/727/2006(H2N3)NIBRG-107InfluenzaReagent08/278InfluenzaAntigenA/Brisbane/10/2007-like(PreparedfromA/Uruguay/716/2007(NYMCX-175C))InfluenzaReagent08/282Follicle-StimulatingHormone,human,recombinant,forbioassay(2ndInternationalStandard)WHOInternationalStandard08/298InfluenzaVirusInfectiousB/Brisbane/33/200830720E5InfluenzaReagent08/300InfluenzaVirusInfectiousIVR-148InfluenzaReagent08/304InfluenzavirusinfectiousNYMCX-175CInfluenzaReagent08/318-007HumanNorovirusGIWorkingReagentforNucleicAcidAmplificationTestingClinicalVirologyNetworkCVN08/320-007HumanMetapneumovirusWorkingReagentforNucleicAcidAmplificationTestingClinicalVirologyNetworkCVN08/322-006HumanParechovirusWorkingReagentforNucleicAcidAmplificationTestingClinicalVirologyNetworkCVN08/324-005HumanRhinovirusGenogroupAWorkingReagentforNucleicAcidAmplificationTestingClinicalVirologyNetworkCVN08/356InfluenzaantiserumA/Japan/305/57(H2)InfluenzaReagent08/362InfluenzaAntigenA/NewYork/107/2003(H7N2)NIBRG-109InfluenzaReagent09/100InfluenzaantiA/mallard/England/727/2006(N3)NAserum(NIBRG-107)(SheepSH503)InfluenzaReagent09/110ParvovirusB19DNANucleicAcidAmplificationTechnology(NAT)basedassaysGenotypePanel(1stInternationalStandard)WHOInternationalStandard09/112NegativeControlforuseinflowcytometrycrossmatching(FCXM)andanti-HLAserologyCEMarkedMaterial09/130InfluenzaVirusInfectiousNIBRG-122InfluenzaReagent09/132-004HumanCoronavirus229EWorkingReagentforNucleicAcidAmplificationTestingClinicalVirologyNetworkCVN09/136GranulocyteColonyStimulatingFactor(Human,rDNADerived)(2ndInternationalStandard)WHOInternationalStandard09/138GeneticReferencePanel,forthequantitationofBCR-ABLtranslocationbyRQ-PCR(1stI.S.)WHOInternationalStandard09/140PraderWilli&AngelmanSyndromes,HumangDNA,(1stInternationalGeneticReferencePanel)WHOInternationalStandard09/148InfluenzaantiA/NewYork/107/2003(H7)HAserum(SheepSH504andSH505)InfluenzaReagent09/154Clostridiumsordellii(Gas-gangrene)Antitoxin,Equine,(1stInternationalstandard)WHOInternationalStandard09/162HumanCytomegalovirus(HCMV)forNucleicAcidAmplificationTechniques(1stInternationalStandard)WHOInternationalStandard09/170Anti-MeningococcalfactorHbindingproteinvariant1(JAR4)monoclonalantibodyNonWHOReferenceMaterial09/172BloodcoagulationFactorsII,VII,IX,XPlasma(4thInternationalStandard2010)WHOInternationalStandard09/174InfluenzaAntigenA/California/7/09(H1N1)v(NYMCX-179A)(CellDerived)InfluenzaReagent09/182VWFFactorConcentrate(2ndInternationalStandard)WHOInternationalStandard09/184InfluenzaAntigenA/Vietnam/1194/2004(H5N1)NIBRG-14InfluenzaReagent09/186Chagas(anti-TrypanosomacruziII)antibodyinhumanplasma(1stInternationalStandard)WHOInternationalStandard09/188Chagas(anti-TrypanosomacruziI)antibodyinHumanPlasma(1stInternationalStandard)WHOInternationalStandard09/196InfluenzaAntigenA/California/7/09(H1N1)v(NIBRG-121xp)(EggDerived)InfluenzaReagent09/222Humananti-HaemophilusinfluenzaebreferenceserumCEMarkedMaterial09/234TransformingGrowthFactor-BETA3(Human,rDNAderivedTGF-?3)(1stInternationalStandard)WHOInternationalStandard09/236InfluenzaVirusInfectiousIVR-153InfluenzaReagent09/242FibrinogenConcentrate(B)(2ndInternationalStandard)WHOInternationalStandard09/260Epstein-BarrVirusforNucleicAcidAmplificationTechniques(1stInternationalStandard)WHOInternationalStandard09/264FibrinogenPlasma(D)(3rdInternationalStandard)WHOInternationalStandard09/266GLIALCELL-DERIVEDNEUROTROPHICFACTOR(GDNF),human,rDNA-derivedNonWHOReferenceMaterial09/268InfluenzaVirusInfectiousNIBRG-121xpInfluenzaReagent09/272PlacentalgrowthfactorAla21-Arg149,human,rDNA-derived(PlGF,PlGF-1)NonWHOReferenceMaterial09/274InfluenzaVirusInfectiousNYMCX-185InfluenzaReagent09/280InfluenzaVirusInfectiousNIB-64InfluenzaReagent09/284Anti-HumanNeutrophilAntibody1aWHOReferenceReagentInternationalReferenceReagent09/296Pro-Insulin,human(1stInternationalStandard)WHOInternationalStandard09/304InfluenzaVirusInfectiousIVR-155InfluenzaReagent09/306InfluenzaVirusInfectiousNIBRG-147InfluenzaReagent09/308InfluenzaSerologyAntigenReagentX-179A(H1N1pdm)forHIAssayWorkingStandard09/310InfluenzaAntigenA/Wisconsin/15/09(H3N2)(NYMCX-183)InfluenzaReagent09/316InfluenzaAntiBNeuraminidaseSerum(B/Florida/4/2006)InfluenzaReagent09/B584-15QCRTHAVQC1-TotalAnti-HAVQualityControlSerum:Sample1QualityControlReagent10/104ReteplaseReferenceMaterialNonWHOReferenceMaterial10/120InfluenzaAntiA/Brisbane/59/2007(IVR148)(H1N1)HAserumInfluenzaReagent10/128DiphtheriaPolyclonalAntibodyNonWHOReferenceMaterial10/130DiphtheriaMonoclonalAntibodyNonWHOReferenceMaterial10/132TetanusPolyclonalAntibodyNonWHOReferenceMaterial10/134TetanusMonoclonalAntibodyNonWHOReferenceMaterial10/136-001HLA-DRB1GenotypingReferencePanelCEMarkedMaterial10/140Anti-humanpapillomavirus[HPV]18serum(1stInternationalStandard)WHOInternationalStandard10/142NegativecontrolforLuminexbasedanti-HLAserologyCEMarkedMaterial10/164OralPoliovaccineSabinType1referencestrain[LS-c,2abstrain].InternationalReferenceReagent10/168OralPoliovaccineSabinType3referenceInternationalReferenceReagent10/176Interleukin-29(InterferonLamda1)InternationalReferenceReagent10/178Endotoxin(3rdInternationalStandard)WHOInternationalStandard10/188FactorVIIIConcentrate(13thBritishStandard).WorkingStandard10/198Anti-malaria(Plasmodiumfalciparum)humanserum(1stInternationalReferenceReagent)InternationalReferenceReagent10/202Influenzaantibody(Human)toA/California/7/2009'like'(H1N1v)virus(2ndInternationalStandard)WHOInternationalStandard10/214InfluenzaAntiN2NeuraminidaseSerumSH395&SH396InfluenzaReagent10/218InfluenzaAntiA/California/7/2009(N1)NASerumInfluenzaReagent10/226InfluenzaVirusInfectiousIVR-158InfluenzaReagent10/232GenomicDNAforbloodgroupgenotypingRBC1(AR1R1)(InternationalReferenceReagent)InternationalReferenceReagent10/234GenomicDNAforbloodgroupgenotypingRBC12(ODpsi)(InternationalReferenceReagent)InternationalReferenceReagent10/236GenomicDNAforbloodgroupgenotypingRBC4(OR1R2)(InternationalReferenceReagent)InternationalReferenceReagent10/238GenomicDNAforbloodgroupgenotypingRBC5(Brr)(InternationalReferenceReagent)InternationalReferenceReagent10/242ToxoplasmagondiiDNANucleicAcidAmplificationTechniques(1stInternationalStandard)WHOInternationalStandard10/252FactorVIIConcentrate(2ndInternationalStandard)WHOInternationalStandard10/258InfluenzaAntigenA/California/7/2009-like(NIB-74)InfluenzaReagent10/262DiphtheriaAntitoxinHumanIgG(1stInternationalStandard)WHOInternationalStandard10/2664thWHOInternationalStandardforHBVDNAforNATWHOInternationalStandard10/272BCGvaccineofMoreau-RJsub-strain(1stInternationalReferenceReagent)InternationalReferenceReagent10/280Anti-HLAControlCEMarkedMaterial10/286FollicleStimulatingHormone,LuteinizingHormonehuman,urinaryforbioassay(5thInternationalStandard)WHOInternationalStandard10/B596-11QCRHSV1QC1-Anti-HSV1QualityControlSerum:Sample1QualityControlReagent1050IPVELISAMAbsType1,2and3(Type2;No:1050)NonWHOReferenceMaterial11/106InfluenzaVirusinfectiousA/Perth/16/2009InfluenzaReagent11/108InfluenzaVirusinfectiousNYMCX-187InfluenzaReagent11/126FactorsIIandXConcentrate(4thInternationalstandard)WHOInternationalStandard11/130InfluenzaVirusInfectiousNIBRG-14InfluenzaReagent11/134InfluenzaAntigenA/California/7/2009(H1N1)Like(A/Brisbane/10/2010-cellderived)InfluenzaReagent11/170Erythropoietin,recombinant,forBioassay(3rdInternationalStandard)WHOInternationalStandard11/176(3rdInternationalStandard)LowMolecularWeightHeparinWHOInternationalStandard11/184HighMolecularWeightUrokinase(2ndInternationalStandard)WHOInternationalStandard11/206Influenzaanti-A/Perth/16/2009HASerumInfluenzaReagent11/210Anti-humanCD4FITCconjugated0.5mlCEMarkedMaterial11/214BloodGroupGenotypingReferencePanel((InternationalReferenceReagent)InternationalReferenceReagent11/216ChagasAntibodyReferencePanel(1stInternationalStandard)WHOInternationalStandard11/218-001MLH1/MSH2ExonCopyNumberReferencePanelCEMarkedMaterial11/222InfluenzaVirusInfectiousNIB-79InfluenzaReagent11/226InfluenzaVirusInfectiousA/Victoria/361/2011InfluenzaReagent11/232InfluenzaVirusInfectiousB/Texas/6/2011InfluenzaReagent11/234ImmunoglobulinE(IgE)humanserum(3rdInternationalStandard)WHOInternationalStandard11/242-001ViralMultiplexReferenceNonWHOReferenceMaterial11/244InfluenzaVirusInfectiiousNYMCBX-49InfluenzaReagent11/B604-02QCRFLUAH5QC1InfluenzaH5PC1QualityControlReagent11/B606-07QCRNEGQC1-NegativeQualityControlSerum:Sample1QualityControlReagent11/B608-03QCRHIV1QC1-Anti-HIV1:QualityControlSerum:Sample1QualityControlReagent12/100InfluenzaVirusInfectiousNYMCX-217InfluenzaReagent12/104InternationalStandardforIPV12/104(3rdInternationalStandard)WHOInternationalStandard12/106InfluenzaAntigenB/Hubei-Wujiagang/158/2009(NYMCBX-39)InfluenzaReagent12/110InfluenzaAntigenB/Wisconsin/1/2010(cellderived)InfluenzaReagent12/112InfluenzaAntigenA/Victoria/210/2009(H3N2)(NYMCX-187)InfluenzaReagent12/114InfluenzaAntigenA/Victoria/361/2011(H3N2)(IVR-165)InfluenzaReagent12/116Influenzaanti-A/Victoria/361/2011-likeHAserumInfluenzaReagent12/118Influenzaanti-B/Wisconsin/1/2010-likeHAserumInfluenzaReagent12/122InfluenzavirusinfectiousA/turkey/Italy/3889/1999InfluenzaReagent12/154TumourNecrosisFactoralpha(humanrDNAderived)(3rdInternationalStandard)WHOInternationalStandard12/176MethylatedHumanSerumAlbumin(mHSA)NonWHOReferenceMaterial12/188PegylatedGranulocyteColonyStimulatingFactor(Human,rDNAderived)(InternationalStandard)WHOInternationalStandard12/198InfluenzavirusinfectiousB/Wisconsin/1/201034490E5InfluenzaReagent12/202InfluenzavirusinfectiousNYMCBX-39InfluenzaReagent12/204InfluenzaVirusinfectiousIVR-165InfluenzaReagent12/208ParvovirusB19(3rdInternationalStandard)WHOInternationalStandard12/224HIV-1NATsubtypes(Main)(2ndInternationalReferencePanelPreparation)InternationalReferencePreparation12/226HBsAg(HBVgenotypeB4,HBsAgsubtypesayw1/adw2)(3rdInternationalStandard)WHOInternationalStandard12/252ADAMTS13Plasma(1stInternationalStandard)WHOInternationalStandard12/282DiphtheriaToxin1Lf/mlNonWHOReferenceMaterial12/284Anti-meningococcalserogroupYmonoclonalantibodyNonWHOReferenceMaterial12/290InfluenzaVirusInfectiousB/Brisbane/36/2012InfluenzaReagent12/294InfluenzaVirusInfectiousNYMCBX-51CInfluenzaReagent12/298InfluenzaVirusInfectiousA/Texas/50/2012InfluenzaReagent12/306HaemophilusInfluenzaePolysaccharidePolyribosylRibitolPhosphate(PRP)(2ndInternationalStandard)WHOInternationalStandard12/B611-03Anti-VZVQualitycontrolserum:Sample1QCRVZVIgMQC1QualityControlReagent12/B612-05QCRRUBIgMQC1-Anti-RubellaIgMQualityControlSerum:Sample1QualityControlReagent12/B613-06QCRRUBQC2-Anti-Rubella:QualityControlSerum:Sample2QualityControlReagent13/100ActivatedBloodCoagulationFactorXI(FXIa),Human(1stInternationalStandard)WHOInternationalStandard13/106InfluenzaAntigenB/Massachusetts/02/2012InfluenzaReagent13/108Anti-MeningococcalserogroupBmonoclonalantibodyNonWHOReferenceMaterial13/112InfluenzaAntigenA/Texas/50/2012(NYMCX-223)InfluenzaReagent13/116InfluenzaAntigenA/Texas/50/2012(NYMCX-223A)InfluenzaReagent13/122ErythropoietinAntibodyReferencePanelNegativeControlAntibody(1stWHOReferencePanel)WHOInternationalStandard13/126Influenzaanti-B/Brisbane/60/2008-likeHAserumInfluenzaReagent13/132Antibodies,Human,toToxoplasmagondii(4thInternationalStandard).WHOInternationalStandard13/134InfluenzaAntigenB/Massachusetts/02/2012(Eggderived)InfluenzaReagent13/146C-Peptide,Human(1stInternationalStandard).WHOInternationalStandard13/152InfluenzaAntigenB/Massachusetts/02/2012(cellderived)InfluenzaReagent13/162InfluenzaAntigenA/Texas/50/2012(NYMCX-223A)(Cellderived)InfluenzaReagent13/164InfluenzaAntigenA/California/7/2009(H1N1pdm)(NYMCX-179A)InfluenzaReagent13/166Influenzaanti-A/Anhui/1/2013(N9)NASerumInfluenzaReagent13/168-002HumanMeaslesMvi/MoscowRus/1988GenotypeAVirusforNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN13/172LupusAnticoagulant(1stInternationalReferencePanel)InternationalReferencePreparation13/176InfluenzaVirusInfectiousNIBRG-88InfluenzaReagent13/178InfluenzaAnti-A/Texas/50/2012-likeHASerumInfluenzaReagent13/182InfluenzaAnti-B/Massachusetts/02/2012-likeHASerumInfluenzaReagent13/198InfluenzaVirusInfectiousNYMCX-181InfluenzaReagent13/200InfluenzaVirusInfectiousNIB-74InfluenzaReagent13/202InfluenzaVirusInfectiousNIB-74xpInfluenzaReagent13/204TNFRecII-FCFusionprotein(1stInternationalStandard)WHOInternationalStandard13/206Plasmin(4thInternationalStandard)WHOInternationalStandard13/212DiphtheriaToxoidforuseinFlocculationTest(3rdInternationalStandard)WHOInternationalStandard13/214HIV-1CirculatingRecombinantFormsRNA(1stInternationalReferencePanel)InternationalReferencePreparation13/216Anti-meningococcalfactorHbindingproteinvariant1(JAR5)monoclonalNonWHOReferenceMaterial13/218PolioAntiSabintype1(inactivated)SerumNonWHOReferenceMaterial13/220PolioAntiSabintype2(inactivated)serumNonWHOReferenceMaterial13/222PolioAntiSabintype3(inactivated)serumNonWHOReferenceMaterial13/224InfluenzavirusInfectiousNIB-85.36210E5InfluenzaReagent13/228InfluenzaVirusInfectious.A/Almaty/2958/2013.35790E4InfluenzaReagent13/234InfluenzaantigenB/Brisbane/60/08InfluenzaReagent13/238Anti-EV71serumLOW(WHOInternationalReferenceReagent)WHOInternationalStandard13/242FEIBAConcentrate2ndNIBSCWorkingReferenceStandardWorkingStandard13/246MeningococcalserogroupApolysaccharide(1stWHOInternationalStandard).WHOInternationalStandard13/248InfluenzavirusinfectiousNIBRG-267InfluenzaReagent13/250InfluenzaVirusInfectiousNIBRG-268InfluenzaReagent13/252InfluenzavirusinfectiousNYMCX-223AInfluenzaReagent13/256Influenzavirusinfectious.NYMCx-233InfluenzaReagent13/258InfluenzavirusinfectiousNYMCX-233AInfluenzaReagent13/264InfluenzaVirusInfectiousNYMCX-223InfluenzaReagent13/B627-05QCRMALQC1-Anti-MalariaQualityControlSerum:Sample1QualityControlReagent13/B629-05QCRHBeQC1-Anti-HBeQualityControlSerum:sample1QualityControlReagent13/B631-05QCRHBsGQC1-HBsAgQualityControlSerum:Sample1QualityControlReagent13/B634-04QCRHAVIgMQC2IgMAnti-HAVQualityControlSerum:Sample2QualityControlReagent13/B636-05QCRHIV1QC2-Anti-HIV1:QualityControlSerum:Sample2QualityControlReagent13/B640-02QCRHIV1QC5-Anti-HIV-1QualityControlReagentSample5QualityControlReagent13/B642-06QCRHSV2QC1-Anti-HSV2QualityControlSerum:Sample1QualityControlReagent13/B644-03QCRHIV1QC3-Anti-HIV1:QualityControlSerum:Sample3QualityControlReagent13/B650-02QCRCMVQC1-AntiCMV:QualityControlSerum:Sample1QualityControlReagent14/106Influenzavirusinfectious.NYMCBX-51BInfluenzaReagent14/114JCVirus(JCV)DNA(1stInternationalStandard)WHOInternationalStandard14/116InfluenzavirusinfectiousNYMCX-179AInfluenzaReagent14/118InfluenzavirusinfectiousB/Massachusetts/2/2012InfluenzaReagent14/1401stInternationalStandardforAntiEV71SerumHumanWHOInternationalStandard14/144Influenzaanti-N2Neuraminidaseserum(A/Victoria/361/2011)InfluenzaReagent14/146InfluenzaAntigenB/Brisbane/60/2008(NYMCBX-35)(CellDerived)InfluenzaReagent14/148HumanBloodFactorIXConcentrate(5thInternationalStandard).WHOInternationalStandard14/150HepatitisCvirus(HCV)Fornucleicacidamplificationtechniques(5thInternationalstandard2015)WHOInternationalStandard14/156MeningococcalgroupXpolysaccharide(1stWHOInternationalStandard)WHOInternationalStandard14/160Hightitreanti-AinIVIGworkingreferencereagentWorkingStandard14/174BotulinumTypeAAntitoxin,EquineNonWHOReferenceMaterial14/198-003HBV,HCV,HIVMultiplexCEMarkedMaterial14/200InfluenzaAntigenA/PuertoRico/8/34(HINI)InfluenzaReagent14/204InfluenzaVirusInfectiousB/Brisbane/9/2014InfluenzaReagent14/206InfluenzavirusinfectiousNYMCX-247InfluenzaReagent14/212BKVirus(BKV)(1stInternationalStandard)WHOInternationalStandard14/224Influenzavirusinfectious.A/Switzerland/9715293/2013InfluenzaReagent14/226InfluenzaVirusInfectiousA/SouthAustralia/55/2014InfluenzaReagent14/228InfluenzaVirusInfectiousA/Stockholm/6/2014InfluenzaReagent14/230InfluenzaVirusInfectious.A/Norway/466/2014InfluenzaReagent14/232InfluenzaVirusInfectiousIVR-175InfluenzaReagent14/240-005BritishWorkingStandardforAnti-HCVCEMarkedMaterial14/242-003Anti-HCV(1in8dilution)(BritishWorkingStandard)CEMarkedMaterial14/246InfluenzaVirusInfectiousNIBRG-301InfluenzaReagent14/254InfluenzaAntigenA/Switzerland/9715293/2013(NIB88)InfluenzaReagent14/274InfluenzaAntigenB/Brisbane/9/2014(EggDerived)InfluenzaReagent14/2904thHCVRNAGenotypePanelforNucleicAcidAmplificationNonWHOReferenceMaterial14/300Hightitreanti-Aandanti-Binserum(WHOReferenceReagent).WHOInternationalStandard14/306InfluenzaVirusInfectiousNYMCX-24340180E13InfluenzaReagent14/308InfluenzaVirusInfectiousIVR-17840200E7InfluenzaReagent14/312InfluenzaVirusInfectiousB/Phuket/3073/2013InfluenzaReagent14/314InfluenzaVirusInfectiousNIB-88InfluenzaReagent14/318InfluenzaAntiNIBRG-301(H5)HASerum(SheepSH624andSH625)InfluenzaReagent14/320InfluenzaVirusInfectiousB/Utah/9/2014InfluenzaReagent14/322InfluenzaVirusInfectiousNIB-91InfluenzaReagent14/B651-02QCRTHBcQC2-TotalAnti-HBcQualityControlSerum:Sample2QualityControlReagent14/B653-01QCRHIV2QC3-AntiHIV2:QualityControlSerum:Sample3QualityControlReagent14/B654-03QCRRUBQC1-Anti-RubellaQualityControlSerum:Sample1QualityControlReagent14/B655-03QCRVZVQC1-AntiVZV:QualityControlSerum:Sample1QualityControlReagent15/100InfluenzaAntigenB/Utah/9/2014(CellDerived)InfluenzaReagent15/104InfluenzaAntigenA/SouthAustralia/55/2014CellderivedInfluenzaReagent15/106AncrodWHOInternationalStandard15/130-001ClinicalVirologyMultiplexI:ImmunodeficiencypanelworkingreagentforNucleicAcidAmplificationTests(NAT)ClinicalVirologyNetworkCVN15/134InfluenzaAnti-ASwitzerland/9715293/2013-LikeHAserumInfluenzaReagent15/136EBOVRNANP-VP35-GPin-runcontrolInternationalReferenceReagent15/138EBOVRNAVP40-Lin-runcontrolInternationalReferenceReagent15/140BatroxobinNonWHOReferenceMaterial15/146InfluenzaVirusInfectiousB/Brisbane/60/2008InfluenzaReagent15/148InfluenzaVirusInfectiousNIB-92InfluenzaReagent15/150Influenzaanti-B/Phuket/3073/2013HAserumInfluenzaReagent15/154InfluenzaVirusInfectiousNIB-93InfluenzaReagent15/158InfluenzaVirusInfectiousNYMCX-263InfluenzaReagent15/160InfluenzaVirusInfectiousNIBRG-306InfluenzaReagent15/174Anti-dsDNAserumNonWHOReferenceMaterial15/180BloodCoagulationFactorXI,PlasmaHuman2ndISWHOInternationalStandard15/1827thBritishWorkingStandardforBloodCoagulationFactorsII,IX,XConcentrateWorkingStandard15/184InfluenzaVirusInfectiousNYMCX-263BInfluenzaReagent15/188InfluenzaVirusInfectiousNYMCX-263AInfluenzaReagent15/192InfluenzaVirusInfectiousA/HongKong/4801/2014InfluenzaReagent15/194InfluenzaVirusInfectiousNYMCX-257AInfluenzaReagent15/196InfluenzaVirusInfectiousNYMCX-261InfluenzaReagent15/212InfluenzaVirusInfectiousNYMCBX-53CInfluenzaReagent15/220Anti-EBOVplasma,human(WHOReferenceReagent)InternationalReferenceReagent15/222EBOVRNANP-VP35-GP(WHOReferenceReagent)InternationalReferenceReagent15/224EBOVRNAVP40-L(WHOReferenceReagent)InternationalReferenceReagent15/234InfluenzaVirusInfectiousB/Texas/2/201341340E7InfluenzaReagent15/238InfluenzaAntigenA/NewCaledonia/71/2014(NYMCX-257A)(Eggderivedantigen)InfluenzaReagent15/240ErythropoietinAntibodyReferencePanelA(1stWHOReferencePanel)WHOInternationalStandard15/242ErythropoietinAntibodyReferencePanelB(1stWHOReferencePanel)WHOInternationalStandard15/248InfluenzaAntiA/Anhui/1/2013(H7)HASerum(SheepSH644&SH645)InfluenzaReagent15/250InfluenzaVirusInfectiousNYMCBX-31InfluenzaReagent15/252InfluenzaVirusInfectiousA/California/7/2009InfluenzaReagent15/262Anti-EBOVConvalescentPlasmaPool-SierraLeone(InternationalReferenceReagent)InternationalReferenceReagent15/274InfluenzaVirusInfectiousNYMCBX-59AInfluenzaReagent15/294InfluenzavirusinfectiousNYMCBX-59BInfluenzaReagent15/298InfluenzaVirusInfectiousB/Brisbane/46/2015InfluenzaReagent15/300InfluenzaVirusInfectiousNYMCBX-3541950E11InfluenzaReagent15/312InfluenzaAnti-B/Brisbane/60/2008HASerumInfluenzaReagent15/B658-03QCRLYMEQC1-Anti-LymeQC1QualityControlReagent15/B661-04QCRLYMEIgMQC1-IgMAnti-LymeQC1QualityControlReagent15/B664-02QCRMUMPSQC1-Anti-MumpsQualityControlReagentSample1QualityControlReagent15/B667-03QCRMEASQC1Anti-MeaslesQC1QualityControlReagent15/B669-02QCRHCVQC1-Anti-HCVQualityControlSerum:Sample1QualityControlReagent15/B671-02QCRHIV1P24QC1-HIV1p24Antigen:QualityControlSerum:Sample1QualityControlReagent15/B673-02QCRSYPHQC1-Anti-SyphilisQualityControlSerum:Sample1QualityControlReagent15/B675-03QCRSYPHQC2-Anti-SyphilisQualityControlSerum:sample2QualityControlReagent15/B678-02QCRPARVB19QC1Anti-ParvovirusB19QC1QualityControlReagent15/B680-01QCRHBsQC1-AntiHBsQualityControlSerum:Sample1QualityControlReagent16/104-001NorovirusGIIWorkingreagentforNucleicAcidAmplificationTechniquesClinicalVirologyNetworkCVN16/106InfluenzaantigenA/California/7/09(H1N1)(NYMC-X181)液体处理,移液器,移液枪,手动移液器,可调移液枪,微量移液,大容量移液,8道移液器,12道移液枪,多道移液器,电动移液枪,移液工作站,移液管,巴斯德吸管,巴氏管,助吸器,瓶口分液器,移液器支架,原装吸头,盒装管嘴,吸头盒,移液器维修,移液枪校准,,Genex,Biohit,百得,Sartorius,赛多利斯,Proline,mLINE,Tacta,ePet,eLINE,Picus,MidiPlus,Dispenser,Gilson,吉尔森,Pipetman,Eppendorf,艾本德,Researchplus,DragonLab,大龙,TopPette,Thermo,Fisher,热电,Finnpipette,Brand,普兰德,Transferpette,Rainin,梅特勒,瑞宁,pipet-Lite,Socorex-----------------------------------------------------------PEG修饰剂,聚乙二醇修饰剂,PEG衍生物,聚乙二醇衍生物,单官能团PEG,PEG-NH2,PEG-COOH,PEG-SH,PEG-NHS,PEG-SC,PEG-MAL,PEG-N3,PEG-***,PEG-ALD,PEG-Silane,PEG-Hydrazide,PEG-Alkyne,双官能团PEG,NH2-PEG-NH2,COOH-PEG-COOH,Mal-PEG-Mal,NHS-PEG-NHS,NH2-PEG-COOH,Boc-NH-PEG-OH,FMOC-NH-PEG-COOH,NH2-PEG-OH,SH-PEG-COOH,SH-PEG-NH2,MAL-PEG-NHS,Biotin-PEG-NH2,多臂PEG,4臂PEG,6臂PEG,8臂PEG,4arm,6arm,8arm,4arm-PEG-NH2,4arm-PEG-COOH,4arm-PEG-SH,8Arm-PEG-SG,短链PEG,单分散PEG,Boc-NH-PEG2-NH2,Boc-NH-PEG2-COOH,SH-PE***-NH2,磷脂PEG,PEG-PE,mPEG-DSPE,DSPE-PEG-NH2,DSPE-PEG-COOH,DSPE-PEG-Biotin,DSPE-PEG-Mal,聚乳酸PEG,PEG-PLA,PEG-PLGA,PLGA-PEG-PLGA,PLA-PEG-PLA,PLGA-PEG-COOH,PLGA-PEG-NH2,PLGA-PEG-FA,CY7-PEG-NH2,FITC-PEG-NH2,cy5-PEG-DSPE,cy3-PEG-DSPE,温敏水凝胶,NANOCS,ProChimia,Surfaces,Rapp-polymere,Laysan,LaysanBio,Creative,PEGWorks,SunBio,BroadPharm,POLYPURE,NOF,QUANTA,Chemicell,Celares,BioVectra-----------------------------------------------------------2ml透明棕色进样瓶,样品瓶,顶空瓶,螺口瓶,液相瓶,玻璃瓶,解析瓶,储存瓶,液体储存瓶,样品瓶架,进样瓶架,解析瓶架,储存瓶架,样品瓶盒,储存瓶盒,针式过滤器,针头过滤器,针筒式滤头,水系,有机相,微孔滤膜,过滤头,津腾,滤头,尼龙66,PES,PTFE,色谱柱,HPLC,液相色谱,气相色谱,内插管,***灯,检测器,Agilent,安捷伦,Waters,沃特世,岛津-----------------------------------------------------------短型玻璃巴斯德吸管,长型玻璃巴斯德吸管,加长巴氏吸管,巴斯德滴管,巴氏滴管,取样管,吸管消毒桶,吸管灭菌桶,移液管消毒罐,滴管灭菌罐,硅胶胶头,吸管胶头,滴管皮头,硅胶吸球,硅胶头,硅胶帽,巴斯德管头,一次性塑料巴斯德吸管,定制玻璃巴斯德吸管-----------------------------------------------------------标准品,对照品,NIBSC标准品,抗原,***,标品,英国***生物标准与检定所标品,美国药典,USP,欧洲药典,EP,加拿大TRC,中检所-----------------------------------------------------------聚乙二醇修饰化学和PEG修饰剂选择指南移液器的日常清洗和维护***样品瓶和隔垫的选择指南http:///news/欢迎致电垂询了解更多详情。************************************************************http:///Tel:021-37773473,18017917942,18019112618QQ:1524395163,55050959,26255569微信：yarebio801，Xueningjinjin，snailer7942************************************************************)